Walleye Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.51M | Sell |
93,800
-31,700
| -25% | -$2.61M | 0.01% | 924 |
|
|
2025
Q4 | $10.7M | Buy |
125,500
+89,700
| +251% | +$7.36M | 0.02% | 892 |
|
|
2025
Q3 | $2.78M | Sell |
35,800
-8,100
| -18% | -$633K | ﹤0.01% | 1599 |
|
|
2025
Q2 | $3.43M | Sell |
43,900
-77,500
| -64% | -$5.78M | 0.01% | 1416 |
|
|
2025
Q1 | $8.8M | Buy |
121,400
+102,500
| +542% | +$7.34M | 0.02% | 799 |
|
|
2024
Q4 | $1.4M | Sell |
18,900
-9,100
| -33% | -$637K | ﹤0.01% | 1922 |
|
|
2024
Q3 | $1.85M | Sell |
28,000
-90,400
| -76% | -$6.57M | ﹤0.01% | 1721 |
|
|
2024
Q2 | $10.9M | Buy |
118,400
+37,800
| +47% | +$3.35M | 0.03% | 639 |
|
|
2024
Q1 | $7.7M | Buy |
80,600
+18,100
| +29% | +$1.52M | 0.02% | 860 |
|
|
2023
Q4 | $4.77M | Buy |
62,500
+34,400
| +122% | +$2.39M | 0.01% | 1275 |
|
|
2023
Q3 | $1.95M | Sell |
28,100
-11,700
| -29% | -$940K | 0.01% | 1799 |
|
|
2023
Q2 | $3.75M | Sell |
39,800
-2,000
| -5% | -$174K | 0.01% | 1178 |
|
|
2023
Q1 | $3.46M | Sell |
41,800
-9,500
| -19% | -$747K | 0.01% | 1312 |
|
|
2022
Q4 | $3.83M | Sell |
51,300
-35,500
| -41% | -$2.74M | 0.01% | 1229 |
|
|
2022
Q3 | $7.17M | Buy |
86,800
+57,800
| +199% | +$5.56M | 0.02% | 794 |
|
|
2022
Q2 | $2.76M | Buy |
29,000
+14,500
| +100% | +$1.5M | 0.01% | 1413 |
|
|
2022
Q1 | $1.71M | Buy |
14,500
+13,500
| +1,350% | +$1.51M | 0.01% | 1786 |
|
|
2021
Q4 | $130K | Sell |
1,000
-8,000
| -89% | -$933K | ﹤0.01% | 4236 |
|
|
2021
Q3 | $1.02M | Buy |
9,000
+4,900
| +120% | +$559K | ﹤0.01% | 2180 |
|
|
2021
Q2 | $425K | Buy |
4,100
+1,200
| +41% | +$113K | ﹤0.01% | 3090 |
|
|
2021
Q1 | $243K | Sell |
2,900
-15,400
| -84% | -$1.3M | ﹤0.01% | 3444 |
|
|
2020
Q4 | $1.67M | Buy |
18,300
+1,300
| +8% | +$108K | 0.01% | 1533 |
|
|
2020
Q3 | $1.36M | Buy |
17,000
+9,200
| +118% | +$718K | 0.01% | 1415 |
|
|
2020
Q2 | $539K | Buy |
7,800
+1,500
| +24% | +$107K | ﹤0.01% | 2224 |
|
|
2020
Q1 | $396K | Buy |
6,300
+2,100
| +50% | +$151K | ﹤0.01% | 2053 |
|
|
2019
Q4 | $327K | Buy |
4,200
+1,800
| +75% | +$141K | ﹤0.01% | 2743 |
|
|
2019
Q3 | $176K | Sell |
2,400
-1,800
| -43% | -$126K | ﹤0.01% | 3018 |
|
|
2019
Q2 | $259K | Sell |
4,200
-31,800
| -88% | -$1.92M | ﹤0.01% | 2741 |
|
|
2019
Q1 | $2.3M | Buy |
36,000
+1,500
| +4% | +$85.6K | 0.02% | 960 |
|
|
2018
Q4 | $1.76M | Sell |
34,500
-2,700
| -7% | -$137K | 0.01% | 1172 |
|
|
2018
Q3 | $2.16M | Buy |
37,200
+10,500
| +39% | +$514K | 0.01% | 1247 |
|
|
2018
Q2 | $1.3M | Buy |
26,700
+10,500
| +65% | +$490K | 0.01% | 1801 |
|
|
2018
Q1 | $753K | Buy |
16,200
+2,100
| +15% | +$91.2K | ﹤0.01% | 2240 |
|
|
2017
Q4 | $529 | Sell |
14,100
-11,700
| -45% | -$429K | ﹤0.01% | 2549 |
|
|
2017
Q3 | $942 | Sell |
25,800
-3,600
| -12% | -$137K | ﹤0.01% | 1930 |
|
|
2017
Q2 | $1.16K | Sell |
29,400
-1,200
| -4% | -$43.8K | 0.01% | 1629 |
|
|
2017
Q1 | $958 | Sell |
30,600
-43,200
| -59% | -$1.35M | 0.01% | 1684 |
|
|
2016
Q4 | $2.31M | Buy |
73,800
+32,100
| +77% | +$1.04M | 0.02% | 869 |
|
|
2016
Q3 | $1.68M | Sell |
41,700
-900
| -2% | -$33.9K | 0.01% | 1108 |
|
|
2016
Q2 | $1.42M | Buy |
42,600
+1,800
| +4% | +$61.6K | 0.01% | 1288 |
|
|
2016
Q1 | $1.2M | Sell |
40,800
-21,000
| -34% | -$579K | 0.01% | 1238 |
|
|
2015
Q4 | $1.63M | Buy |
61,800
+25,200
| +69% | +$654K | 0.02% | 888 |
|
|
2015
Q3 | $868K | Sell |
36,600
-22,800
| -38% | -$550K | 0.01% | 1162 |
|
|
2015
Q2 | $1.41M | Buy |
59,400
+34,800
| +141% | +$785K | 0.01% | 899 |
|
|
2015
Q1 | $582K | Sell |
24,600
-23,400
| -49% | -$525K | 0.01% | 1377 |
|
|
2014
Q4 | $1.02M | Buy |
48,000
+23,400
| +95% | +$470K | 0.01% | 1024 |
|
|
2014
Q3 | $418K | Sell |
24,600
-15,600
| -39% | -$246K | ﹤0.01% | 1479 |
|
|
2014
Q2 | $577 | Sell |
40,200
-78,000
| -66% | -$1.06M | 0.01% | 1158 |
|
|
2014
Q1 | $1.46K | Sell |
118,200
-277,800
| -70% | -$3.21M | 0.02% | 632 |
|
|
2013
Q4 | $4.34M | Buy |
396,000
+257,400
| +186% | +$2.9M | 0.04% | 328 |
|
|
2013
Q3 | $1.61M | Buy |
138,600
+111,000
| +402% | +$1.3M | 0.02% | 640 |
|
|
2013
Q2 | $309K | Buy |
+27,600
| New | +$327K | ﹤0.01% | 1487 |
|
Other funds holding EW
VCM
VPM
Walleye Trading's EW Position: Q1 2026 in Review
Walleye Trading increased its Edwards Lifesciences (EW) stake by 21% in Q1 2026, buying an estimated $74.2K and bringing the position to 5,124 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.
Walleye Trading first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $4.77M in Q3 2018. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Walleye Trading held 5,124 shares of Edwards Lifesciences worth $410K as of Q1 2026.
- Walleye Trading bought 900 Edwards Lifesciences shares in Q1 2026, an estimated $74.2K.
- Edwards Lifesciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2710 holding.
- Walleye Trading first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
- Walleye Trading's Edwards Lifesciences position peaked at $4.77M in Q3 2018.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.